---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-123211"
form_type: "8-K"
ticker: "PROF"
cik: "0001628808"
company_name: "Profound Medical Corp."
filed_at: "2025-12-19T23:59:59+00:00"
generated_at: "2026-05-16T12:34:49.915009+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Profound Medical prices $36M registered direct offering and up to $4M private placement at $7.00/share

## Summary
- Sold 5,142,870 common shares at $7.00 each in registered direct offering; gross proceeds ~$36M.
- Planned private placement in Canada of up to 571,428 common shares at $7.00 for up to $4M additional proceeds.
- Both tranches have no warrant coverage; placement agent is Konik Capital Partners (5% cash fee).
- Registered direct closing expected Dec 22, 2025; private placement closing on or before Dec 30, 2025.
- Net proceeds for sales/marketing expansion, working capital, R&D, and strategic transactions.

## SEC filing metadata
- accession: 0001104659-25-123211
- form_type: 8-K
- ticker: PROF
- cik: 0001628808
- company_name: Profound Medical Corp.
- filed_at: 2025-12-19T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1628808/000110465925123211/0001104659-25-123211-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1628808/000110465925123211/tm2533900d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-123211
- JSON: https://secwatch.observer/filing/0001104659-25-123211.json
- Plain text: https://secwatch.observer/filing/0001104659-25-123211.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.